NYSE:DLBDolby Laboratories Stock Price, Forecast & News

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DLB stock has increased by 9.3% and is now trading at $65.82. View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Dolby Laboratories.

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Dolby Laboratories.

Dolby Laboratories, Inc. (NYSE:DLB) released its quarterly earnings data on Monday, May, 4th. The electronics maker reported $1.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.09 by $0.05. The electronics maker earned $351.82 million during the quarter, compared to analysts' expectations of $361.35 million. Dolby Laboratories had a return on equity of 9.45% and a net margin of 17.74%. The company's quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.04 EPS. View Dolby Laboratories' earnings history.

Dolby Laboratories announced a quarterly dividend on Monday, May 4th. Shareholders of record on Monday, May 18th will be paid a dividend of $0.22 per share on Wednesday, May 27th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend is Friday, May 15th. View Dolby Laboratories' dividend history.

Dolby Laboratories updated its third quarter earnings guidance on Monday, May, 4th. The company provided EPS guidance of $0.18-0.35 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.72. The company issued revenue guidance of $225-250 million, compared to the consensus revenue estimate of $309.08 million.

6 brokerages have issued 12-month target prices for Dolby Laboratories' stock. Their forecasts range from $65.00 to $72.00. On average, they expect Dolby Laboratories' stock price to reach $69.00 in the next twelve months. This suggests a possible upside of 4.8% from the stock's current price. View analysts' price targets for Dolby Laboratories.

News headlines about DLB stock have trended extremely negative this week, InfoTrie reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Dolby Laboratories earned a news sentiment score of -4.0 on InfoTrie's scale. They also assigned news headlines about the electronics maker a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Dolby Laboratories.

Dolby Laboratories saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 1,130,000 shares, a drop of 18.1% from the June 15th total of 1,380,000 shares. Based on an average daily trading volume, of 475,600 shares, the short-interest ratio is presently 2.4 days. Approximately 1.8% of the shares of the company are short sold. View Dolby Laboratories' Current Options Chain.

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Rogers (ROG) and Vishay Intertechnology (VSH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include Metlife (MET), AT&T (T), Netflix (NFLX), Comcast (CMCSA), Walt Disney (DIS), Activision Blizzard (ATVI), Brighthouse Financial (BHF), InterDigital Wireless (IDCC), Las Vegas Sands (LVS) and Hasbro (HAS).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a number of institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.12%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton. View institutional ownership trends for Dolby Laboratories.

DLB stock was bought by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. View insider buying and selling activity for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $65.82.

Dolby Laboratories has a market capitalization of $6.63 billion and generates $1.24 billion in revenue each year. The electronics maker earns $255.15 million in net income (profit) each year or $2.44 on an earnings per share basis. Dolby Laboratories employs 2,193 workers across the globe.

The official website for Dolby Laboratories is www.dolby.com.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]